The Scientists Against Malaria consortium is a virtual drug discovery organization collaborating on target selection and modeling, protein expression and assay development, computational drug design, and screening. Supported by developments on the EU FP7 funded SYNERGY and OpenTox projects, a combination of interoperable information systems, ontologies and web services were designed and deployed to manage the data, documents, computational and assay results, activity and toxicology predictions, as well as dashboards to track project progress and to support decision making.
Collaborative Virtual Organization and Infrastructure for Anti-Malarial Drug Design / B. Hardy, R. Affentranger, A. Contini, H. Gutierrez de Teran, J. Wiseman, M. Clark, J. Spitzner, R. Papoian, W. Seibel, S. Nelson, S. Bryant, A. Wilks, I. Lucet, C. Doerig. ((Intervento presentato al convegno Bio-IT World Conference & Expo tenutosi a Boston nel 2011.
Collaborative Virtual Organization and Infrastructure for Anti-Malarial Drug Design
A. Contini;
2011
Abstract
The Scientists Against Malaria consortium is a virtual drug discovery organization collaborating on target selection and modeling, protein expression and assay development, computational drug design, and screening. Supported by developments on the EU FP7 funded SYNERGY and OpenTox projects, a combination of interoperable information systems, ontologies and web services were designed and deployed to manage the data, documents, computational and assay results, activity and toxicology predictions, as well as dashboards to track project progress and to support decision making.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
